Skip to main content
Journal cover image

Power considerations when a continuous outcome variable is dichotomized.

Publication ,  Journal Article
Deyi, BA; Kosinski, AS; Snapinn, SM
Published in: J Biopharm Stat
May 1998

An investigator can compare two groups with respect to a continuous outcome variable, Y, by comparing the means of Y or by collapsing that variable into categories. For example, antihypertensive treatments can be compared on the basis of blood pressure measurements, or on the basis of the proportions of patients with blood pressure in prespecified ranges. This report is concerned with the loss of power when inherently continuous variables are dichotomized. The report will focus on the power loss when a normally distributed variable with a known, common variance in each of two groups is dichotomized. Power is shown to depend on the relationship between the means of the two groups and the cutoff point, and it varies from negligible to substantial. The results will be applied to data from the Lovastatin Restenosis Trial. Initially the trial considered a dichotomous outcome (proportion of patients with elevated percent diameter stenosis), but the endpoint was later changed to the mean percent diameter stenosis. The modification in the design of the trial was well justified because the power loss was considerable when comparing proportions.

Duke Scholars

Published In

J Biopharm Stat

DOI

ISSN

1054-3406

Publication Date

May 1998

Volume

8

Issue

2

Start / End Page

337 / 352

Location

England

Related Subject Headings

  • Statistics & Probability
  • Sample Size
  • Research Design
  • Population
  • Humans
  • Drug Therapy
  • Algorithms
  • 4905 Statistics
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Deyi, B. A., Kosinski, A. S., & Snapinn, S. M. (1998). Power considerations when a continuous outcome variable is dichotomized. J Biopharm Stat, 8(2), 337–352. https://doi.org/10.1080/10543409808835243
Deyi, B. A., A. S. Kosinski, and S. M. Snapinn. “Power considerations when a continuous outcome variable is dichotomized.J Biopharm Stat 8, no. 2 (May 1998): 337–52. https://doi.org/10.1080/10543409808835243.
Deyi BA, Kosinski AS, Snapinn SM. Power considerations when a continuous outcome variable is dichotomized. J Biopharm Stat. 1998 May;8(2):337–52.
Deyi, B. A., et al. “Power considerations when a continuous outcome variable is dichotomized.J Biopharm Stat, vol. 8, no. 2, May 1998, pp. 337–52. Pubmed, doi:10.1080/10543409808835243.
Deyi BA, Kosinski AS, Snapinn SM. Power considerations when a continuous outcome variable is dichotomized. J Biopharm Stat. 1998 May;8(2):337–352.
Journal cover image

Published In

J Biopharm Stat

DOI

ISSN

1054-3406

Publication Date

May 1998

Volume

8

Issue

2

Start / End Page

337 / 352

Location

England

Related Subject Headings

  • Statistics & Probability
  • Sample Size
  • Research Design
  • Population
  • Humans
  • Drug Therapy
  • Algorithms
  • 4905 Statistics
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences